Found 12 hits for monomerid = 3220 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Protein kinase C alpha type
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 460 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 45: 2624-43 (2002)
Article DOI: 10.1021/jm020018f BindingDB Entry DOI: 10.7270/Q2BG2M50 |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 45: 2624-43 (2002)
Article DOI: 10.1021/jm020018f BindingDB Entry DOI: 10.7270/Q2BG2M50 |
More data for this Ligand-Target Pair | |
Protein kinase C, epsilon
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 370 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 45: 2624-43 (2002)
Article DOI: 10.1021/jm020018f BindingDB Entry DOI: 10.7270/Q2BG2M50 |
More data for this Ligand-Target Pair | |
cAMP-Dependent Protein Kinase (PKA)
(Bos taurus (bovine)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB
UniProtKB/SwissProt
GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone. |
J Med Chem 45: 2624-43 (2002)
Article DOI: 10.1021/jm020018f BindingDB Entry DOI: 10.7270/Q2BG2M50 |
More data for this Ligand-Target Pair | |
Protein kinase C, eta
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of Protein kinase C eta |
Bioorg Med Chem Lett 5: 2015-2020 (1995)
Article DOI: 10.1016/0960-894X(95)00344-S BindingDB Entry DOI: 10.7270/Q29C6XD1 |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 430 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of Protein kinase C beta 1 |
Bioorg Med Chem Lett 5: 2015-2020 (1995)
Article DOI: 10.1016/0960-894X(95)00344-S BindingDB Entry DOI: 10.7270/Q29C6XD1 |
More data for this Ligand-Target Pair | |
Protein kinase C alpha type
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 460 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of Protein kinase C alpha |
Bioorg Med Chem Lett 5: 2015-2020 (1995)
Article DOI: 10.1016/0960-894X(95)00344-S BindingDB Entry DOI: 10.7270/Q29C6XD1 |
More data for this Ligand-Target Pair | |
Protein kinase C delta type
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of Protein kinase C delta |
Bioorg Med Chem Lett 5: 2015-2020 (1995)
Article DOI: 10.1016/0960-894X(95)00344-S BindingDB Entry DOI: 10.7270/Q29C6XD1 |
More data for this Ligand-Target Pair | |
Protein kinase C, epsilon
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 370 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of Protein kinase C epsilon |
Bioorg Med Chem Lett 5: 2015-2020 (1995)
Article DOI: 10.1016/0960-894X(95)00344-S BindingDB Entry DOI: 10.7270/Q29C6XD1 |
More data for this Ligand-Target Pair | |
Protein kinase C (PKC)
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of Protein kinase C zeta |
Bioorg Med Chem Lett 5: 2015-2020 (1995)
Article DOI: 10.1016/0960-894X(95)00344-S BindingDB Entry DOI: 10.7270/Q29C6XD1 |
More data for this Ligand-Target Pair | |
Protein kinase C, gamma
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of Protein kinase C gamma |
Bioorg Med Chem Lett 5: 2015-2020 (1995)
Article DOI: 10.1016/0960-894X(95)00344-S BindingDB Entry DOI: 10.7270/Q29C6XD1 |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3220
(2-{[2,6-dihydroxy-4-({[(1R,2R)-2-[(4-hydroxybenzen...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(CO[C@@H]2CCC[C@H]2NC(=O)c2ccc(O)cc2)cc1O |r| Show InChI InChI=1S/C27H25NO9/c29-16-9-7-15(8-10-16)26(34)28-18-4-2-6-22(18)37-13-14-11-20(31)24(21(32)12-14)25(33)23-17(27(35)36)3-1-5-19(23)30/h1,3,5,7-12,18,22,29-32H,2,4,6,13H2,(H,28,34)(H,35,36)/t18-,22-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of Protein kinase C beta 2 |
Bioorg Med Chem Lett 5: 2015-2020 (1995)
Article DOI: 10.1016/0960-894X(95)00344-S BindingDB Entry DOI: 10.7270/Q29C6XD1 |
More data for this Ligand-Target Pair | |